Alkyne-βAG-TOCA

Alkyne-βAG-TOCA, an octreotide derivative, targets somatostatin receptor type 2 (SST2) [1]. Alkyne-βAG-TOCA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .

C48H65N11O15S2

1100.22

O=C(NCCC(NCC(N[C@H](CC1=CC=CC=C1)C(N[C@@H](CSSC[C@@H](NC([C@H]([C@@H](C)O)NC2=O)=O)C(N[C@H]([C@H](C)O)C(O)=O)=O)C(N[C@@H](CC3=CC=C(O)C=C3)C(NCC(N[C@H]2CCCCN)=O)=O)=O)=O)=O)=O)C#C

Somatostatin Receptor

98.99

DMSO : 50 mg/mL (ultrasonic)

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice